367 461

Cited 3 times in

The Combination of TRAIL Treatment and Cancer Cell Selective Expression of TRAIL-Death Receptor DR4 Induces Cell Death in TRAIL-Resistant Cancer Cells

 Eunah Choi  ;  Youngtae Kim  ;  Kunhong Kim 
 YONSEI MEDICAL JOURNAL, Vol.47(1) : 55-62, 2006 
Journal Title
Issue Date
Adenoviridae/genetics ; Antineoplastic Agents/pharmacology* ; Apoptosis/drug effects* ; Apoptosis Regulatory Proteins/genetics ; Apoptosis Regulatory Proteins/metabolism ; Apoptosis Regulatory Proteins/pharmacology* ; Cell Line ; DNA-Binding Proteins/genetics ; Drug Resistance, Neoplasm ; Humans ; Membrane Glycoproteins/genetics ; Membrane Glycoproteins/metabolism ; Membrane Glycoproteins/pharmacology* ; Neoplasms/genetics ; Neoplasms/metabolism ; Neoplasms/pathology ; Promoter Regions, Genetic ; Receptors, TNF-Related Apoptosis-Inducing Ligand ; Receptors, Tumor Necrosis Factor/genetics ; Receptors, Tumor Necrosis Factor/metabolism* ; TNF-Related Apoptosis-Inducing Ligand ; Telomerase/genetics ; Tumor Necrosis Factor-alpha/genetics ; Tumor Necrosis Factor-alpha/metabolism ; Tumor Necrosis Factor-alpha/pharmacology*
Neoplasms ; TNF-related apoptosis-inducing ligand ; human telomerase reverse transcriptase promoter ; death receptor-4 ; adenoviridae
The human telomerase reverse transcriptase (hTERT) promoter can be used for the tumor-specific expression of transgenes in order to induce selective cancer cell death. The hTERT core promoter is active in cancer cells but not in normal cells. To examine whether the combination of TNF-related apoptosis inducing ligand (TRAIL) treatment and cancer cell-selective expression of the TRAIL-death receptor could induce cell death in TRAIL-resistant cancer cells, we generated a death receptor-4 (DR4)-expressing adenovirus (Ad-hTERT-DR4), in which the expression of DR4 is driven by the hTERT promoter. Upon infection, DR4 expression was slightly increased in cancer cell lines, and cell death was observed in TRAIL-resistant cancer cell lines but not in normal human cells when DR4 infection was combined with TRAIL treatment. We also generated an adenovirus that expresses a secretable isoleucine zipper (ILZ)-fused, extracellular portion of TRAIL (Ad-ILZ-TRAIL). In cells infected with Ad-ILZ-TRAIL, TRAIL was expressed, secreted, oligomerized and biologically active in the induction of apoptosis in TRAIL-sensitive cancer cells. When Ad-hTERT-DR4 infected TRAIL-resistant HCE4 cells and Ad-ILZ-TRAIL infected TRAIL-resistant HCE7 cells were co-cultured, cell deaths were evident 24 h after co-culture. Taken together, our results reveal that the combination of TRAIL and cancer cell-specific expression of DR4 has the potential to overcome the resistance of cancer cells to TRAIL without inducing significant cell death in normal cells.
Files in This Item:
T200601328.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Biochemistry and Molecular Biology (생화학-분자생물학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Obstetrics and Gynecology (산부인과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Kun Hong(김건홍) ORCID logo https://orcid.org/0000-0001-5639-6372
Kim, Young Tae(김영태) ORCID logo https://orcid.org/0000-0002-7347-1052
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.